|
KHZ
|
Cancer Parathyroid
|
2750
30
304370
480
519340
520
55910
613690
706530
7500
|
|
ETDF
|
Cancer Pheochromocytoma
|
115830
30890
3210
322500
434500
452500
490
60
697500
730
875350
|
|
BIO
|
Cancer Plasmacytoma
|
475
|
|
PROV
|
Cancer Prostate
|
1875
1998
20
2008
2050
2120
2127
2128
2130
2217
2250
2720
304
442
5000
666
690
72
727
766
787
790
800
920
|
|
CAFL
|
Cancer Prostate 1
|
2125
2128
2131
2140
2145
3672
666
|
|
XTRA
|
Cancer Prostate 2
|
10025
125
1840
1875
1998
20
2008
2050
2120
2125
2127
2130
2131
2140
2145
2217
2250
2288
2720
304
3672
408
442
5000
60
660
688
690
72
727.5
748
766
787
790
800
854
920
95
|
|
ETDF
|
Cancer Prostate 2a
|
130
2250
325710
434160
527000
570
667000
742000
830
97500
|
|
XTRA
|
Cancer Prostate 2b
|
130
2250
325710
475160
527000
570
667000
742000
830
97500
|
|
XTRA
|
Cancer Prostate 3
|
125
1875
1998
20
2008
2050
2120
2127
2128
2130
2217
2250
2720
304
442
5000
60
666
690
72
727
766
787
790
800
920
95
|
|
XTRA
|
Cancer Prostate 4
|
1840
2145
2288
854
|
|
ETDF
|
Cancer Rectal
|
150000
17500
27500
37500
434000
460
571000
840000
85000
95750
|
|
ETDF
|
Cancer Residual
|
15900
248000
434500
524370
52810
601270
610
62710
781090
97530
|
|
KHZ
|
Cancer Respiratory Tract Neoplasms
|
100
172850
230000
483200
535230
550
608210
67200
730
870
|
|
CAFL
|
Cancer Rhabdomyosarcoma
|
2000
2005
2008
2016
2048
2084
2093
2100
2127
2128
2184
2217
464
6024
6384
728
784
880
|
|
ETDF
|
Cancer Rhabdomyosarcoma
|
120
205690
270
317250
34210
412500
692500
776950
838250
9330
|
|
CAFL
|
Cancer Rhabdomyosarcoma Embryonal
|
2000
2005
2008
2016
2032
2040
2048
2060
2084
2093
2100
2127
2128
2184
2217
2586
464
6024
6384
728
784
880
|
|
CAFL
|
Cancer Rhabdomyosarcoma Embryonal Vega 1
|
2586
4445
5476
|
|
CAFL
|
Cancer Sarcoma
|
2000
2008
2127
727
787
880
|
|
XTRA
|
Cancer Sarcoma 2
|
1755
2005
2007.5
2015.9
2083.8
3524
728
785
802
880
|
|
CAFL
|
Cancer Sarcoma General
|
1755
2008
3524
|
